OptimizeRx (OPRX) Announces Quarterly Earnings Results

OptimizeRx (OTCMKTS:OPRX) posted its earnings results on Monday. The technology company reported $0.02 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.01 by $0.01, Morningstar.com reports. The firm had revenue of $5.42 million during the quarter, compared to analyst estimates of $5.28 million.

Shares of OTCMKTS:OPRX opened at $17.07 on Tuesday. OptimizeRx has a 12 month low of $2.30 and a 12 month high of $18.39.

In related news, insider Douglas P. Baker sold 4,784 shares of the firm’s stock in a transaction on Friday, August 10th. The shares were sold at an average price of $12.01, for a total transaction of $57,455.84. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

A number of brokerages recently commented on OPRX. Lake Street Capital raised their price objective on shares of OptimizeRx to $14.00 and gave the stock a “buy” rating in a report on Wednesday, August 8th. B. Riley raised their price objective on shares of OptimizeRx from $15.00 to $17.00 and gave the stock a “buy” rating in a report on Wednesday, August 8th. Finally, Zacks Investment Research upgraded shares of OptimizeRx from a “hold” rating to a “strong-buy” rating and set a $15.00 price objective on the stock in a report on Tuesday, August 21st.

COPYRIGHT VIOLATION NOTICE: “OptimizeRx (OPRX) Announces Quarterly Earnings Results” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/11/06/optimizerx-oprx-announces-quarterly-earnings-results.html.

About OptimizeRx

OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria.

Read More: Closed-End Mutual Funds (CEFs)

Earnings History for OptimizeRx (OTCMKTS:OPRX)

Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply